MUMBAI, India, May 9 -- Intellectual Property India has published a patent application (202537039084 A) filed by Gemvax & Kael Co. Ltd., Daejeon, Republic of Korea, on April 23, for 'peptide for treating or preventing 4r tauopathy.'
Inventor(s) include Kim, Sang Jae.
The application for the patent was published on May 9, under issue no. 19/2025.
According to the abstract released by the Intellectual Property India: "One aspect of the present invention relates to: a pharmaceutical composition or a food composition for preventing, treating, or ameliorating 4R tauopathy, the composition comprising, as an active ingredient, one or more selected from the group consisting of a peptide including an amino acid sequence of SEQ ID NO: 1, a peptide...